Viracta Therapeutics (NASDAQ:VIRX) reported its Q3 earnings results on Thursday, November 9, 2023 at 08:30 AM.
Here’s what investors need to know about the announcement.
Earnings
Viracta Therapeutics missed estimated earnings by 10.0%, reporting an EPS of $-0.33 versus an estimate of $-0.3.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04 which was followed by a 7.8% drop in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Viracta Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
